Literature DB >> 26108868

Effort-Based Decision Making in Schizophrenia: Evaluation of Paradigms to Measure Motivational Deficits.

Michael F Green1, William P Horan2.   

Abstract

Effort-based decision making requires one to decide how much effort to expend for a certain amount of reward. As the amount of reward goes up most people are willing to exert more effort. This relationship between reward level and effort expenditure can be measured in specialized performance-based tasks that have only recently been applied to schizophrenia. Such tasks provide a way to measure objectively motivational deficits in schizophrenia, which now are only assessed with clinical interviews of negative symptoms. The articles in this theme provide reviews of the relevant animal and human literatures (first 2 articles), and then a psychometric evaluation of 5 effort-based decision making paradigms (last 2 articles). This theme section is intended to stimulate interest in this emerging area among basic scientists developing paradigms for preclinical studies, human experimentalists trying to disentangle factors that contribute to performance on effort-based tasks, and investigators looking for objective endpoints for clinical trials of negative symptoms in schizophrenia.
© The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  effort-based decision making; motivation; negative symptoms

Mesh:

Year:  2015        PMID: 26108868      PMCID: PMC4535648          DOI: 10.1093/schbul/sbv084

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  10 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Pathways between early visual processing and functional outcome in schizophrenia.

Authors:  Y Rassovsky; W P Horan; J Lee; M J Sergi; M F Green
Journal:  Psychol Med       Date:  2010-05-19       Impact factor: 7.723

4.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

5.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.

Authors:  L Felice Reddy; William P Horan; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Naomi Lyons; Stephen R Marder; Michael T Treadway; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-03       Impact factor: 9.306

Review 6.  Translational Rodent Paradigms to Investigate Neuromechanisms Underlying Behaviors Relevant to Amotivation and Altered Reward Processing in Schizophrenia.

Authors:  Jared W Young; Athina Markou
Journal:  Schizophr Bull       Date:  2015-07-20       Impact factor: 9.306

Review 7.  Effort-Based Decision Making: A Novel Approach for Assessing Motivation in Schizophrenia.

Authors:  Michael F Green; William P Horan; Deanna M Barch; James M Gold
Journal:  Schizophr Bull       Date:  2015-06-18       Impact factor: 9.306

Review 8.  Anhedonia in schizophrenia: a review of assessment strategies.

Authors:  William P Horan; Ann M Kring; Jack J Blanchard
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

9.  Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 2—External Validity and Correlates.

Authors:  William P Horan; L Felice Reddy; Deanna M Barch; Robert W Buchanan; Eduardo Dunayevich; James M Gold; Steven R Marder; Jonathan K Wynn; Jared W Young; Michael F Green
Journal:  Schizophr Bull       Date:  2015-07-23       Impact factor: 9.306

10.  Negative symptoms of schizophrenia are associated with abnormal effort-cost computations.

Authors:  James M Gold; Gregory P Strauss; James A Waltz; Benjamin M Robinson; Jamie K Brown; Michael J Frank
Journal:  Biol Psychiatry       Date:  2013-02-07       Impact factor: 13.382

  10 in total
  7 in total

1.  Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.

Authors:  Lauren Luther; Melanie W Fischer; Ruth L Firmin; Michelle P Salyers
Journal:  Schizophr Res       Date:  2018-12-19       Impact factor: 4.939

Review 2.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

3.  The relationships among aberrant salience, reward motivation, and reward sensitivity.

Authors:  Suzanne R Neumann; Richard J Linscott
Journal:  Int J Methods Psychiatr Res       Date:  2018-04-24       Impact factor: 4.035

4.  Altered experiential, but not hypothetical, delay discounting in schizophrenia.

Authors:  William P Horan; Matthew W Johnson; Michael F Green
Journal:  J Abnorm Psychol       Date:  2017-02-06

Review 5.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

Review 6.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 7.  Issues and developments related to assessing function in serious mental illness.

Authors:  Matt A Brown; Dawn I Velligan
Journal:  Dialogues Clin Neurosci       Date:  2016-06       Impact factor: 5.986

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.